MoneyWorks4Me

Sanjivani Paranteral informs about initial disclosure

24 Apr 2025 Evaluate
Pursuant to the Circular Ref. No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 read with Circular No. SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 dated October 19, 2023 (‘SEBI Circulars’), Sanjivani Paranteral has informed that the company is not identified as ‘Large Corporate’ as per the framework provided in the aforesaid Circulars.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..